Find Lafutidine manufacturers, exporters & distributors on PharmaCompass

Lafutidine

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 5 JDMF, 9 KDMF, 6 Listed Suppliers, $ API Reference Price

11 API Suppliers
5 JDMF
9 KDMF
6 Listed Suppliers
$ API Reference Price

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

2 FDF Dossiers, 2 Listed Dossiers

2 FDF Dossiers
2 Listed Dossiers

DIGITAL CONTENT

2 NEWS #PharmaBuzz

media
2 NEWS #PharmaBuzz

MARKET PLACE

7 APIs

marketPlace
7 APIs

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

API

FDF

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 118288-08-7, 206449-93-6, Frg-8813, Lafutidine [inn], (z)-lafutidine, Lafutidine [jan]

Molecular Formula

C₂₂H₂₉N₃O₄S

Molecular Weight

431.6 g/mol

InChI Key

KMZQAVXSMUKBPD-DJWKRKHSSA-N

FDA UNII

49S4O7ADLC

Lafutidine has been investigated in Peptic Ulcer, Community-acquired Pneumonia, and Gastroesophageal Reflux Disease (GERD).

1 2D Structure

Lafutidine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-(furan-2-ylmethylsulfinyl)-N-[(Z)-4-[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxybut-2-enyl]acetamide

2.1.2 InChI

InChI=1S/C22H29N3O4S/c26-21(18-30(27)17-20-7-6-14-28-20)23-9-2-5-13-29-22-15-19(8-10-24-22)16-25-11-3-1-4-12-25/h2,5-8,10,14-15H,1,3-4,9,11-13,16-18H2,(H,23,26)/b5-2-

2.1.3 InChI Key

KMZQAVXSMUKBPD-DJWKRKHSSA-N

2.1.4 Canonical SMILES

C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3

2.1.5 Isomeric SMILES

C1CCN(CC1)CC2=CC(=NC=C2)OC/C=C\CNC(=O)CS(=O)CC3=CC=CO3

2.2 Other Identifiers

2.2.1 UNII

49S4O7ADLC

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Frg 8813

2. Frg-8813

3. N-(4-(4-piperidinylmethyl)pyridyl-2-oxy)-(z)-butenyl-2-(furfurylsulfinyl)acetamide

4. N-(4-(4-piperidinylmethyl)pyridyl-2-oxy)butenyl-2-(furfurylsulfinyl)acetamide

2.3.2 Depositor-Supplied Synonyms

1. 118288-08-7

2. 206449-93-6

3. Frg-8813

4. Lafutidine [inn]

5. (z)-lafutidine

6. Lafutidine [jan]

7. Lafutidine Free Base

8. Rac Lafutidine

9. Lafutidine [mart.]

10. Lafutidine [who-dd]

11. Lafutidine, (+/-)-

12. (z)-2-((furan-2-ylmethyl)sulfinyl)-n-(4-((4-(piperidin-1-ylmethyl)pyridin-2-yl)oxy)but-2-en-1-yl)acetamide

13. 49s4o7adlc

14. 118288-08-7 (free Base)

15. 2-(furan-2-ylmethylsulfinyl)-n-[(z)-4-[4-(piperidin-1-ylmethyl)pyridin-2-yl]oxybut-2-enyl]acetamide

16. Acetamide, 2-[(2-furanylmethyl)sulfinyl]-n-[(2z)-4-[[4-(1-piperidinylmethyl)-2-pyridinyl]oxy]-2-buten-1-yl]-

17. Unii-49s4o7adlc

18. Dsstox_cid_26434

19. Dsstox_rid_81611

20. Dsstox_gsid_46434

21. Protecadin

22. (+/-)-2-(furfurylsulfinyl)-n-((z)-4-((4-(piperidinomethyl)-2-pyridyl)oxy)-2-butenyl) Acetamide

23. Cas-118288-08-7

24. Frg 8813

25. Laftidine

26. Stogar

27. Protecadin (tn)

28. Ncgc00164550-01

29. N-(4-(4-piperidinylmethyl)pyridyl-2-oxy)butenyl-2-(furfurylsulfinyl)acetamide

30. Starbld0049801

31. Lafutidine (jp17/inn)

32. Mls006011259

33. Schembl362540

34. Chembl1742461

35. Dtxsid0046434

36. Lafutidine, >=98% (hplc)

37. Chebi:31759

38. Hms3884d03

39. Act06288

40. Hy-b0160

41. Tox21_112179

42. Mfcd21607521

43. S2065

44. Akos005146275

45. Tox21_112179_1

46. Ccg-269024

47. Cs-1992

48. Db12770

49. (+-)-2-(furfurylsulfinyl)-n-(4-(4-(piperidinomethyl)-2-pyridyl)oxy-(z)-2-butenyl)acetamide

50. Ncgc00263530-01

51. (+-)-2-(furfurylsulfinyl)-n-((z)-4-((4-(piperidinomethyl)-2-pyridyl)oxy)-2-butenyl) Acetamide

52. Ac-23354

53. Acetamide, 2-((2-furanylmethyl)sulfinyl)-n-(4-((4-(1-piperidinylmethyl)-2-pyridinyl)oxy)-2-butenyl)-, (z)-

54. Smr002529578

55. L0341

56. Sw219706-1

57. D01131

58. F77861

59. Ab01565815_02

60. 288l087

61. L001355

62. Q582556

63. J-521629

64. F0001-2391

2.4 Create Date

2005-06-24

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₉N₃O₄S
Molecular Weight	431.6 g/mol
XLogP3	1.4
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	7
Rotatable Bond Count	11
Exact Mass	431.18787759 g/mol
Monoisotopic Mass	431.18787759 g/mol
Topological Polar Surface Area	104 Å²
Heavy Atom Count	30
Formal Charge	0
Complexity	569
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	1
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)

Histamine H2 Antagonists

Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. (See all compounds classified as Histamine H2 Antagonists.)

4.2 ATC Code

A - Alimentary tract and metabolism

A02 - Drugs for acid related disorders

A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BA - H2-receptor antagonists

A02BA08 - Lafutidine

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

01

Bajaj Healthcare

India

Antibody Engineering

Not Confirmed

02

Boryung Pharmaceutical Co., Ltd

South Korea

Antibody Engineering

Not Confirmed

03

CKD Bio Corporation

South Korea

Antibody Engineering

Not Confirmed

Not Confirmed

09

Antibody Engineering

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635532200,"product":"LAFUTIDINE JP","address":"","city":"","supplier":"ASTER INTERNATIONAL PHARMACEUTICALS LLP","supplierCountry":"INDIA","foreign_port":"KATHMANDU - TRIBHUVA","customer":"ALIVE PHARMACEUTICALS PVT ","customerCountry":"NEPAL","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"136000","totalValueFC":"3363.9","currency":"INR","unitRateINR":126000,"date":"30-Oct-2021","totalValueINR":"252000","totalValueInUsd":"3363.9","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"5701882","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635532200,"product":"LAFUTIDINE JP","address":"","city":"","supplier":"ASTER INTERNATIONAL PHARMACEUTICALS LLP","supplierCountry":"INDIA","foreign_port":"KATHMANDU - TRIBHUVA","customer":"ALIVE PHARMACEUTICALS PVT ","customerCountry":"NEPAL","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"136000","totalValueFC":"3363.9","currency":"INR","unitRateINR":126000,"date":"30-Oct-2021","totalValueINR":"252000","totalValueInUsd":"3363.9","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"5702379","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1676917800,"product":"LAFUTIDINE JP","address":"601-A, 6TH FLR, MORYA LAND MARK,,I I OSHIWARA LINK RD, ANDHERI WEST","city":"MUMBAI,MAHARASHTRA","supplier":"EASTERN CHEMICALS MUMBAI ","supplierCountry":"INDIA","foreign_port":"SEOUL - INCHEON INT\\'","customer":"TO THE ORDER,","customerCountry":"KOREA, REPUBLIC OF","quantity":"151.00","actualQuantity":"151","unit":"KGS","unitRateFc":"1280","totalValueFC":"191657.5","currency":"USD","unitRateINR":104827.81456953642,"date":"21-Feb-2023","totalValueINR":"15829000","totalValueInUsd":"191657.5","indian_port":"BOMBAY AIR","hs_no":"29333100","bill_no":"7957490","productDescription":"API","marketType":"REGULATED MARKET","country":"KOREA,REPUBLIC OF","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"601-A, 6TH FLR, MORYA LAND MARK,,I I OSHIWARA LINK RD, ANDHERI WEST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1719513000,"product":"LAFUTIDINE JP","address":"N - 216 N-217, M. I. D. C.,","city":"THANE, MAHARASHTRA.","supplier":"BAJAJ HEALTHCARE","supplierCountry":"INDIA","foreign_port":"KARACHI -","customer":"GENIX PHARMA PRIVATE ","customerCountry":"PAKISTAN","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"1500","totalValueFC":"1363.2","currency":"USD","unitRateINR":113800,"date":"28-Jun-2024","totalValueINR":"113800","totalValueInUsd":"1363.2","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"2012330","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"PAKISTAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"N - 216 N-217, M. I. D. C.,, THANE, MAHARASHTRA.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1729967400,"product":"LAFUTIDINE JP BATCH NO. LAF-00040424 MFG. DT. APR.2024 , RETEST DT. MAR.2027","address":"44-FAIZ-E-EDROOS,371-373","city":"MUMBAI ,MAHARASHTRA","supplier":"JAYANA PHARMA","supplierCountry":"INDIA","foreign_port":"BIRGUNJ","customer":"ALIVE PHARMACEUTICAL P ","customerCountry":"NEPAL","quantity":"1.00","actualQuantity":"1","unit":"KGS","unitRateFc":"230","totalValueFC":"2034.4","currency":"INR","unitRateINR":170943.34,"date":"27-Oct-2024","totalValueINR":"170943.34","totalValueInUsd":"2034.4","indian_port":"Raxaul","hs_no":"29420090","bill_no":"5181542","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"NEPAL","selfForZScoreResived":"Pharma Grade","supplierPort":"Raxaul","supplierAddress":"44-FAIZ-E-EDROOS,371-373, MUMBAI ,MAHARASHTRA","customerAddress":""}]